# PT-141 for Men: What the Research Shows | PT-141 Archive > PT-141 for men: a plain-English look at the erectile-activity studies on the melanocortin peptide bremelanotide — and the honest fact that it is not approved for men. The melanocortin peptide was studied in men years before it was approved for women — here is what those studies measured, and the honest limits. ## The short version Most people searching for **PT-141 for men** want one answer: does it do anything for erections, and is it legitimate? Here is the honest picture. In early human studies, PT-141 produced real, dose-dependent erectile activity in men with erectile dysfunction [1][8], including a measurable response through a nasal spray above a 7 mg dose, with first erections at about 30 minutes [8]. So the effect was real and measured in men. But the molecule was **never approved for men**. Its only U.S. approval is for premenopausal women with low sexual desire [7]. Development for male erectile dysfunction stopped, partly over a side effect: the nasal form raised blood pressure in some people [7]. So any use of PT-141 in men today is off-label and investigational — meaning it sits outside what regulators have signed off on. This page summarizes the male studies as studies, not as a recommendation. ## What the male studies measured The first detailed human work used a **nasal spray**. In healthy men and in men with mild-to-moderate erectile dysfunction, intranasal PT-141 showed dose-dependent drug levels in the blood, reached peak levels at about half an hour, cleared with a half-life of roughly 1.85 to 2.09 hours, and produced a statistically significant erectile response versus placebo at doses above 7 mg — with the first erection at around 30 minutes [8]. That is a fast, central trigger. Researchers then moved toward an **injection under the skin** (subcutaneous), studying its safety and how the body handled it in healthy men and in men who had not responded well to a standard erection pill [9]. A separate combination study paired a low intranasal dose with a PDE-5 inhibitor and reported an enhanced erectile response — testing the 'central trigger plus peripheral blood flow' idea [10]. One older study reported benefit in men who had failed a standard pill, but it carries a 2023 Expression of Concern (a formal editorial flag questioning its integrity), so its numbers should be treated as disputed [12]. Detailed outcomes are gathered on [PT-141 results](/results). ## Is PT-141 approved for men No. PT-141 (bremelanotide) is approved in the United States only for **acquired, generalized hypoactive sexual desire disorder in premenopausal women** [7]. It is not approved for men, not approved for postmenopausal women, and not approved to enhance performance in anyone [7]. The male erectile-dysfunction program did not reach approval. That distinction matters for honesty. The studies in men are genuine and the early erectile effect was real [1][8] — but 'studied in men' is not the same as 'approved for men.' A separate point worth flagging: material sold online as a 'PT-141 research chemical' is not the approved medicine and is not quality-controlled for identity, purity, or strength [7]. The approved drug and the gray-market peptide are not interchangeable. ## PT-141 for women Although this page leads with the male research, the strongest human evidence — and the only approval — is in **PT-141 for women** [3][7]. Two large Phase 3 trials in premenopausal women with low sexual desire and distress found that a 1.75 mg as-needed injection improved desire scores and reduced desire-related distress over 24 weeks, with benefit sustained to 52 weeks [3][4]. A 2022 brain-imaging study showed the receptor target, MC4R, directly changed how the brain processes desire [5]. Interestingly, the female story started in animals: in female rats, PT-141 selectively increased solicitation — the proactive, desire-driven behaviors — without changing reflexive responses or general movement, making it the first drug reported to act on appetitive female sexual behavior [2]. The full numbers are on [PT-141 results](/results). ## PT-141 reviews and what people ask Searches for **PT-141 reviews** usually come from men weighing it against an erection pill. The fair summary from the published record: PT-141 acts through a different route — the brain's desire circuitry rather than blood flow [1] — produced real erectile activity in early male studies [1][8], but never cleared approval for men and was set aside partly over a blood-pressure effect [7]. This site does not collect or sell anything, and it publishes no personal testimonials or doses. What it offers is the study record in plain words. For the experiential layer that research-use communities describe — clearly labeled as anecdote, not evidence — see the [PT-141 effects](/effects) page, which keeps reported experiences strictly separate from the cited trial data. --- A wine-dark reading archive of the bremelanotide literature — entries ruled and cited, nothing on these shelves for sale.